2007
DOI: 10.1016/j.jsat.2006.09.005
|View full text |Cite
|
Sign up to set email alerts
|

A stepped care approach for reducing cannabis use in opioid-dependent outpatients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 30 publications
(50 reference statements)
0
14
0
Order By: Relevance
“…In this context, it is not surprising to observe high rates for use of substances other than opiates among MMT patients, and addictive behaviors persisting after treatment initiation (Clarke et al, 2001;Moitra et al, 2013;Richter et al, 2001;SAMHSA, 2012;White et al, 2014). While not appearing to be significant factors of MMT discontinuation, these behaviors may suggest that many patients spend a considerable proportion of recovery time taking other substances and are likely to be exposed to many of the health risks inherent in chronic substance use (Kidorf et al, 2007). Consequently, cannabis use in methadone patients should be monitored more for its own inherent effects on health (dependence syndrome, impaired respiratory function, cardiovascular disease) (Hall, 2015) than for its presumed causal relationship with treatment dropout or heroin or cocaine use (Epstein & Preston, 2003).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this context, it is not surprising to observe high rates for use of substances other than opiates among MMT patients, and addictive behaviors persisting after treatment initiation (Clarke et al, 2001;Moitra et al, 2013;Richter et al, 2001;SAMHSA, 2012;White et al, 2014). While not appearing to be significant factors of MMT discontinuation, these behaviors may suggest that many patients spend a considerable proportion of recovery time taking other substances and are likely to be exposed to many of the health risks inherent in chronic substance use (Kidorf et al, 2007). Consequently, cannabis use in methadone patients should be monitored more for its own inherent effects on health (dependence syndrome, impaired respiratory function, cardiovascular disease) (Hall, 2015) than for its presumed causal relationship with treatment dropout or heroin or cocaine use (Epstein & Preston, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Patients who initiate MMT are likely to concurrently use psychoactive substances other than opiates (Clarke, Stein, McGarry, & Gogineni, 2001;Moitra, Anderson, & Stein, 2013;Richter, Gibson, Ahluwalia, & Schmelzle, 2001;White et al, 2014), in particular cannabis, which is also the most-used illicit substance in industrialized countries (Compton, Thomas, Conway, & Colliver, 2005;Kidorf, Neufeld, King, Clark, & Brooner, 2007). Research results are mixed regarding the effect of MMT on cannabis use, and measurements of the drug's use during treatment are infrequently and irregularly reported in the literature (Amato et al, 2005;SAMHSA, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, while one small study has used a CM approach to sequentially target cocaine use and then cannabis use (Budney, Higgins, Delaney, Kent, & Bickel, 1991), and two other small studies have tested approaches to reducing cannabis use among methadone maintenance patients (Calsyn & Saxon, 1999;Kidorf, Neufeld, King, Clark, & Brooner, 2007), only two psychosocial interventions to date have been developed to explicitly and concurrently target cannabis use disorders and other substance use or psychiatric disorders (Edwards et al, 2006;Hoch et al, 2012).…”
Section: Psychosocial Treatmentmentioning
confidence: 99%
“…With respect to cannabis use disorders, two studies have explicitly endorsed a SCA for reducing cannabis use in comorbid populations (Baker, Turner, Kay-Lambkin, & Lewin, 2009;Kidorf et al, 2007), and other research has evaluated brief interventions and "check-up" approaches that target users who are ambivalent about change (Fischer et al, 2013;Stephens et al, 2004). It is noteworthy that only two psychosocial interventions to date have been explicitly developed and evaluated for the targeted treatment of cannabis use disorders and concurrent addictive or psychiatric disorders (Edwards et al, 2006;Hoch et al, 2012), a population of which might represent one of the upper echelons of cannabis problem severity.…”
Section: Stepped Care Approachmentioning
confidence: 99%
“…Adaptive interventions have been shown to be effective in treating a wide range of substance abuse disorders, including tobacco dependence (Reid, Pipe, Higginson, Johnson, D'Angelo, Cooke et al, 2003), opiate dependence (Brooner, Kidorf, King, Stoller, Peirce, Bigelow & Kolodner, 2004;Brooner, Kidorf, Stoller, Neufeld & Kolodner, 2007;Kidorf, Neufeld & Brooner, 2004;King, Stoller, Hayes, Umbricht, Currens, Kidorf et al, 2002), cannabis abuse (Kidorf, Neufeld, King, Clark & Brooner, 2007), alcoholism (O'Malley, Rounsaville, Farren, Namkoong, Wu, Robinson et al, 2003) and continuing-care interventions for drug dependence (McKay, Lynch, Shepard, Morgenstern, Forman & Pettinatti, 2005, McKay, Lynch, Shepard & Pettinatti, 2005. The specific content and structure of the adaptive interventions vary depending upon the nature of the disorder being treated; however, the findings from these studies suggest that employing standardized criteria for determining when and how to respond to clients' progress or lack thereof in treatment can yield significant improvements beyond that obtained when professionals exercise individualized judgment in specific cases.…”
mentioning
confidence: 99%